# Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism

> **NCT00743782** · PHASE2 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 21 (actual)

## Conditions studied

- Hypoparathyroidism
- Hypocalcemia
- Autoimmune Polyendocrine Syndrome Type 1
- Autosomal Dominant Hypocalcemia Type 1 (ADH1)

## Interventions

- **DRUG:** Synthetic Human Parathyroid Hormone 1-34 pump

## Key facts

- **NCT ID:** NCT00743782
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-22
- **Primary completion:** 2014-04-07
- **Final completion:** 2014-04-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00743782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00743782, "Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00743782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*